3Cao LF. Progress and current stated diagnosis and treatment for refractory Mycoplasma pneumoniae pneumonia in children[J]. Journal of Clinical Pediatrics,2010,(01) :94.
3Marc E, Chaussain M, Moulin F, et al. Reduced lung diffusion capacity after mycoplasma pneumoniae pneumonia [ J]. Pediatr Infect Dis J, 2000, 19 (8): 706-710.
4Youn YS, Lee KY, Hwang JY, et al. Difference of clinical features in childhood Mycoplasma pneumoniae pneumonia [ J]. BMC Pediatr, 2010, 10: 48.
5Hassan J, Irwin F, Dooley S, et al.Mycoplasma pneumoniae infection in a pediatric population: analysis of soluble immune markers as risk factors for asthma.[J].Human Immunology: Official Journal of the American Society for Histoeompatibility and Immunogenetics, 2008, 69(12): 851- 855.
6Zora J E, Sarnat S E, Raysoni A U, et al.Associations between urban air pollution and pediatric asthma control in E1 Paso, Texas[J].Science of the Total Environment, 2013, 448(2): : 56-65.
7Soyer O U, Beyhun N E, Demir E, et al.A multicenter survey of childhood asthma in Turkey.Ⅱ: Utilization of asthma drugs, control levels and their determinants.[J].Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology, 2009, 20(2): 172-179.
8Gendrel D, Biscardi S, Marc E.Mycoplasmapneumoniae, community- acquired pneumonia and asthma[J].Archives de Pediatrie, 2005, 12(Suppl 1): s7-s11.
9Strickland D H, Thomas J A, Mok D, et al.Defective aeroallergen surveillance by airway mueosal dendritic cells as a determinant of risk for persistent airways hyper-responsiveness in experimental asthma[J]. Mucosal Immunology, 2012, 5(3): 332-341.
10Shimizu T,Kida Y,Kuwano K.Cytoadherence-dependent induction of inflmmatory responses by Mycoplasma pneumoniae[J].Immunology,2011,133(1):51-61.
